185 related articles for article (PubMed ID: 19653235)
1. CE provides evidence of the stereoselective hydroxylation of norketamine in equines.
Schmitz A; Theurillat R; Lassahn PG; Mevissen M; Thormann W
Electrophoresis; 2009 Aug; 30(16):2912-21. PubMed ID: 19653235
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective analysis of ketamine and its metabolites in equine plasma and urine by CE with multiple isomer sulfated beta-CD.
Theurillat R; Knobloch M; Schmitz A; Lassahn PG; Mevissen M; Thormann W
Electrophoresis; 2007 Aug; 28(15):2748-57. PubMed ID: 17600844
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro.
Portmann S; Kwan HY; Theurillat R; Schmitz A; Mevissen M; Thormann W
J Chromatogr A; 2010 Dec; 1217(51):7942-8. PubMed ID: 20609441
[TBL] [Abstract][Full Text] [Related]
4. Separation of hydroxynorketamine stereoisomers using capillary electrophoresis with sulfated β-cyclodextrin and highly sulfated γ-cyclodextrin.
Sandbaumhüter FA; Theurillat R; Thormann W
Electrophoresis; 2017 Aug; 38(15):1878-1885. PubMed ID: 28213944
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective CE-MS analysis of ketamine metabolites in urine.
Sandbaumhüter FA; Aerts JT; Theurillat R; Andrén PE; Thormann W; Jansson ET
Electrophoresis; 2023 Jan; 44(1-2):125-134. PubMed ID: 36398998
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective capillary electrophoresis provides insight into the phase II metabolism of ketamine and its metabolites in vivo and in vitro.
Sandbaumhüter FA; Thormann W
Electrophoresis; 2018 Jun; 39(12):1478-1481. PubMed ID: 29572863
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective CE analysis of hepatic ketamine metabolism in different species in vitro.
Schmitz A; Thormann W; Moessner L; Theurillat R; Helmja K; Mevissen M
Electrophoresis; 2010 May; 31(9):1506-16. PubMed ID: 20358543
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the stereoselective biotransformation of ketamine to norketamine via determination of their enantiomers in equine plasma by capillary electrophoresis.
Theurillat R; Knobloch M; Levionnois O; Larenza P; Mevissen M; Thormann W
Electrophoresis; 2005 Oct; 26(20):3942-51. PubMed ID: 16167314
[TBL] [Abstract][Full Text] [Related]
9. Microassay for ketamine and metabolites in plasma and serum based on enantioselective capillary electrophoresis with highly sulfated γ-cyclodextrin and electrokinetic analyte injection.
Theurillat R; Sandbaumhüter FA; Bettschart-Wolfensberger R; Thormann W
Electrophoresis; 2016 May; 37(9):1129-38. PubMed ID: 26626946
[TBL] [Abstract][Full Text] [Related]
10. Development of a method for analysis of ketamine and norketamine enantiomers in equine brain and cerebrospinal fluid by capillary electrophoresis.
Theurillat R; Larenza MP; Feige K; Bettschart-Wolfensberger R; Thormann W
Electrophoresis; 2014 Oct; 35(19):2863-9. PubMed ID: 24789372
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ketamine and three metabolites in Beagle dogs under sevoflurane vs. medetomidine comedication assessed by enantioselective capillary electrophoresis.
Sandbaumhüter FA; Theurillat R; Bektas RN; Kutter APN; Bettschart-Wolfensberger R; Thormann W
J Chromatogr A; 2016 Oct; 1467():436-444. PubMed ID: 27485149
[TBL] [Abstract][Full Text] [Related]
12. Effect of the α
Sandbaumhüter FA; Theurillat R; Bettschart-Wolfensberger R; Thormann W
Electrophoresis; 2017 Aug; 38(15):1895-1904. PubMed ID: 28251651
[TBL] [Abstract][Full Text] [Related]
13. Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS/MS in human serum, urine and fecal samples.
Hasan M; Hofstetter R; Fassauer GM; Link A; Siegmund W; Oswald S
J Pharm Biomed Anal; 2017 May; 139():87-97. PubMed ID: 28279931
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations.
Woolf TF; Adams JD
Xenobiotica; 1987 Jul; 17(7):839-47. PubMed ID: 3660854
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective biotransformation of ketamine in equine liver and lung microsomes.
Schmitz A; Portier CJ; Thormann W; Theurillat R; Mevissen M
J Vet Pharmacol Ther; 2008 Oct; 31(5):446-55. PubMed ID: 19000264
[TBL] [Abstract][Full Text] [Related]
16. Use of human microsomes and deuterated substrates: an alternative approach for the identification of novel metabolites of ketamine by mass spectrometry.
Turfus SC; Parkin MC; Cowan DA; Halket JM; Smith NW; Braithwaite RA; Elliot SP; Steventon GB; Kicman AT
Drug Metab Dispos; 2009 Aug; 37(8):1769-78. PubMed ID: 19448136
[TBL] [Abstract][Full Text] [Related]
17. Validation of an enzyme-linked immunosorbent assay screening method and a liquid chromatography-tandem mass spectrometry confirmation method for the identification and quantification of ketamine and norketamine in urine samples from Malaysia.
Harun N; Anderson RA; Miller EI
J Anal Toxicol; 2009; 33(6):310-21. PubMed ID: 19653934
[TBL] [Abstract][Full Text] [Related]
18. Studies on the biotransformation of ketamine. 1-Identification of metabolites produced in vitro from rat liver microsomal preparations.
Adams JD; Baillie TA; Trevor AJ; Castagnoli N
Biomed Mass Spectrom; 1981 Nov; 8(11):527-38. PubMed ID: 7317567
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective pharmacokinetics of ketamine and norketamine after constant rate infusion of a subanesthetic dose of racemic ketamine or S-ketamine in Shetland ponies.
Larenza MP; Peterbauer C; Landoni MF; Levionnois OL; Schatzmann U; Spadavecchia C; Thormann W
Am J Vet Res; 2009 Jul; 70(7):831-9. PubMed ID: 19566468
[TBL] [Abstract][Full Text] [Related]
20. Urine concentrations of ketamine and norketamine following illegal consumption.
Moore KA; Sklerov J; Levine B; Jacobs AJ
J Anal Toxicol; 2001 Oct; 25(7):583-8. PubMed ID: 11599604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
